Dr. Graham has been Division Director of the Vanderbilt University Medical Center Department of Pediatrics since 2008. Under his direction, the division has grown to include five physicians, three nurse practitioners, and trainees. This growth has enabled expansion to serve areas in the state and region which do not have a pediatric rheumatologist. Clinical interests include juvenile idiopathic arthritis, fibromyalgia, and autoimmune encephalopathy. 

Dr. Graham graduated from Vanderbilt University Medical School in 1992. He completed residency in Pediatrics at the Children's Hospital of Philadelphia and fellowship training in Pediatric Rheumatology at Cincinnati Children's Hospital Medical Center (CCHMC). He remained on faculty at CCHMC and was promoted to Clinical Director. He left CCHMC to become Division Director of Pediatric Rheumatology at Vanderbilt University Medical Center in 2008. Under his direction, the division has grown to include five physicians, three nurse practitioners, and trainees. This growth has enabled expansion to serve areas in the state and region which do not have a pediatric rheumatologist. Clinical interests include juvenile idiopathic arthritis, fibromyalgia, and autoimmune encephalopathy. He received the Amos Christie Award for Resident Teaching in 2012.

Dr. Tanaz Kermani is vasculitis expert and Associate Clinical Professor in the Division of Rheumatology at University of California Los Angeles. She completed her residency and rheumatology fellowship at Mayo Clinic followed by an additional 2 years of vasculitis training also at Mayo Clinic as part of the NIH-sponsored Vasculitis Clinical Research Consortium. She is the Founder and Director of the multi-disciplinary UCLA Vasculitis Program. She is a full-time clinician and active researcher in large-vessel vasculitis with multiple publications. She is a participant in several international collaborative research endeavors.

Tara Skorupa is a rheumatologist and primary care physician at Beth Israel Deaconess Medical Center in Boston, Massachusetts, and an Instructor of Medicine (appointment in process) at Harvard Medical School. During her fellowship at the University of Colorado, Dr. Skorupa demonstrated an early commitment to medical education by serving as content creator for the Sjogren’s Syndrome module of the ACR’s Advanced Rheumatology Course, and presenting multiple sessions on Sjogren’s for the Project ECHO Colorado Series, which provides education on topics in rheumatology for rural PCPs. In her role as a clinician educator since starting as faculty, she has found a niche at the intersection of rheumatology and primary care, aiming to make rheumatology more approachable for a general medicine audience.

Tate Johnson is an Assistant Professor and Early Career Investigator at the University of Nebraska Medical Center with a clinical focus on the management of patients with inflammatory arthritis. He is USSONAR certified and frequently incorporates the use of musculoskeletal ultrasound in patient care.

He has participated in several national committees through the ACR including the Fellows-in-Training subcommittee, the Early Career Investigator subcommittee, and was a question writer for the most recent CARE modules. He currently receives research support from the Rheumatology Research Foundation to investigate cardiovascular disease outcomes in patients with rheumatoid arthritis.

Dr. Mikuls is a native of Omaha, Nebraska, receiving his degrees from Santa Clara University (B.S.), the University of Nebraska Medical Center (MD), and the University of Alabama at Birmingham (M.S.P.H.). He completed his medical residency, including a chief resident year, at the University of Nebraska Medical Center (UNMC) and his training in immunology & rheumatology at UAB in Birmingham, Alabama. He is currently the Stokes-Shackleford Professor in the Division of Rheumatology at UNMC in Omaha. 

Dr. Mikuls is an epidemiologist and rheumatologist, with research interests focused on disease epidemiology, pathogenesis and outcomes in rheumatoid arthritis and gout. He currently leads research efforts of the Nebraska Arthritis Outcomes Research Center and receives active research support from the NIH (NIGMS, NIAMS), VA, Rheumatology Research Foundation, US Department of Defense, and industry. He founded and directs the national VA Rheumatoid Arthritis Registry (VARA) and serves as Director of the Professional Development core for the NIGMS-funded Great Plains IDeA CTR.

Dr. Mikuls is a native of Omaha, Nebraska, receiving his degrees from Santa Clara University (B.S.), the University of Nebraska Medical Center (MD), and the University of Alabama at Birmingham (M.S.P.H.). He completed his medical residency, including a chief resident year, at the University of Nebraska Medical Center (UNMC) and his training in immunology & rheumatology at UAB in Birmingham, Alabama. He is currently the Umbach Professor of Rheumatology at the UNMC in Omaha where he also serves as Vice Chair of Research for the Department of Internal Medicine. 

Dr. Mikuls is an epidemiologist and rheumatologist, with research interests focused on disease epidemiology, pathogenesis and outcomes in rheumatoid arthritis and gout. He currently leads research efforts of the Nebraska Arthritis Outcomes Research Center and receives active research support from the NIH (NIGMS, NIAMS, NIAAA), VA, Rheumatology Research Foundation, US Department of Defense, and industry. He founded and directs the national VA Rheumatoid Arthritis Registry (VARA) and serves as Director of the Professional Development core for the NIGMS-funded Great Plains IDeA CTR.

Dr. Tiffany Lin is an Associate Professor in the Division of Rheumatology at the University of Wisconsin School of Medicine and Public Health. Dr. Lin serves as the Rheumatology Fellowship Program Director as well as Assistant Block Leader in the Invaders and Defense course in the University of Wisconsin medical school curriculum. Her educational interests include spondyloarthritis and basic science teaching for clinical rheumatologists.

Dr. Tiphanie Vogel is a rheumatologist at Baylor College of Medicine in Houston, where she practices at Texas Children's Hospital. Dr. Vogel is board certified in rheumatology and pediatric rheumatology, and in her clinic she treats patients of all ages with rare autoimmune and autoinflammatory disorders. Dr. Vogel also runs a basic science research program. The Vogel Lab aims to improve the lives of patients with rheumatic diseases through enhanced understanding of human immunology. Through basic and translational science initiatives, the Vogel Lab aspires to develop targeted therapies for immune disorders. The Vogel Lab focuses on several key missions: advancement of the understanding of cytokine signals in health and in autoimmune disease, determination of novel genetic causes of autoimmune and immune dysregulatory disorders, and investigation of unique biomarkers and therapeutic targets in pediatric autoimmunity.

Dr. Neogi is Chief of Rheumatology at the Chobanian & Avedisian Boston University School of Medicine/Boston Medical Center. She completed her medical training at the University of Toronto, and her PhD in Epidemiology at Boston University School of Public Health. Her research focuses on risk factors, treatments, and consequences of osteoarthritis and gout. She also devotes time to mentoring trainees and early stage investigators in clinical research.